1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted

2. Executive Summary
2.1. Market Snapshot: Global Post-Traumatic Stress Disorder Therapeutics Market
2.2. Global Post-Traumatic Stress Disorder Therapeutics Market, By Stage, 2023 (US$ Million)
2.3. Global Post-Traumatic Stress Disorder Therapeutics Market, By Age Specific, 2023 (US$ Million)
2.4. Global Post-Traumatic Stress Disorder Therapeutics Market, By Product, 2023 (US$ Million)
2.5. Global Post-Traumatic Stress Disorder Therapeutics Market, By End User, 2023 (US$ Million)
2.6. Global Post-Traumatic Stress Disorder Therapeutics Market, By Geography, 2023 (US$ Million)
2.7. Attractive Investment Proposition by Geography, 2023

3. Post-Traumatic Stress Disorder Therapeutics Market: Competitive Analysis
3.1. Market Positioning of Key Post-Traumatic Stress Disorder Therapeutics Market Vendors
3.2. Strategies Adopted by Post-Traumatic Stress Disorder Therapeutics Market Vendors
3.3. Key Industry Strategies
4. Post-Traumatic Stress Disorder Therapeutics Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Post-Traumatic Stress Disorder Therapeutics Market Value, 2022 - 2032, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis
4.6. Porter's Five Force Model
4.6.1. Supplier Power
4.6.2. Buyer Power
4.6.3. Threat Of Substitutes
4.6.4. Threat Of New Entrants
4.6.5. Competitive Rivalry
4.7. PESTEL Analysis
4.7.1. Political Landscape
4.7.2. Economic Landscape
4.7.3. Technology Landscape
4.7.4. Legal Landscape
4.7.5. Social Landscape

5. Post-Traumatic Stress Disorder Therapeutics Market: By Stage, 2022-2032, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2023 Versus 2032
5.3. Market Segmentation
5.3.1. Impact or Emergency Stage
5.3.2. Denial Stage
5.3.3. Short Term Recovery Stage
5.3.4. Long Term Recovery Stage

6. Post-Traumatic Stress Disorder Therapeutics Market: By Age Specific, 2022-2032, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2023 Versus 2032
6.3. Market Segmentation
6.3.1. Adults
6.3.2. Children

7. Post-Traumatic Stress Disorder Therapeutics Market: By Product, 2022-2032, USD (Million)
7.1. Market Overview
7.2. Growth & Revenue Analysis: 2023 Versus 2032
7.3. Market Segmentation
7.3.1. Antidepressants
7.3.1.1. SSRIs
7.3.1.2. SNRIs
7.3.1.3. MAO Inhibitors
7.3.1.4. Tricyclic Antidepressants
7.3.2. Anti-anxiety Drugs
7.3.2.1. Beta-blockers
7.3.2.2. Benzodiazepines
7.3.3. Other Drug Classes
7.3.3.1. Alpha-1 & Alpha-2 Receptor Antagonists
7.3.3.2. Atypical Antipsychotics
7.3.3.3. Anticonvulsants
7.3.4. Pipeline Candidates (Qualitative Information)
7.3.4.1. SRX 246 (Phase II)
7.3.4.2. BNC 210 (Phase II)
7.3.4.3. Tonmya (Phase II)

8. Post-Traumatic Stress Disorder Therapeutics Market: By End User, 2022-2032, USD (Million)
8.1. Market Overview
8.2. Growth & Revenue Analysis: 2023 Versus 2032
8.3. Market Segmentation
8.3.1. Hospitals
8.3.2. Clinics
8.3.3. Others


9. North America Post-Traumatic Stress Disorder Therapeutics Market, 2022-2032, USD (Million)
9.1. Market Overview
9.2. Post-Traumatic Stress Disorder Therapeutics Market: By Stage, 2022-2032, USD (Million)
9.3. Post-Traumatic Stress Disorder Therapeutics Market: By Age Specific, 2022-2032, USD (Million)
9.4. Post-Traumatic Stress Disorder Therapeutics Market: By Product, 2022-2032, USD (Million)
9.5. Post-Traumatic Stress Disorder Therapeutics Market: By End User, 2022-2032, USD (Million)
9.6.Post-Traumatic Stress Disorder Therapeutics Market: By Region, 2022-2032, USD (Million)
9.6.1.North America
9.6.1.1. U.S.
9.6.1.1.1. Post-Traumatic Stress Disorder Therapeutics Market: By Stage, 2022-2032, USD (Million)
9.6.1.1.2. Post-Traumatic Stress Disorder Therapeutics Market: By Age Specific, 2022-2032, USD (Million)
9.6.1.1.3. Post-Traumatic Stress Disorder Therapeutics Market: By Product, 2022-2032, USD (Million)
9.6.1.1.4. Post-Traumatic Stress Disorder Therapeutics Market: By End User, 2022-2032, USD (Million)
9.6.1.2. Canada
9.6.1.2.1. Post-Traumatic Stress Disorder Therapeutics Market: By Stage, 2022-2032, USD (Million)
9.6.1.2.2. Post-Traumatic Stress Disorder Therapeutics Market: By Age Specific, 2022-2032, USD (Million)
9.6.1.2.3. Post-Traumatic Stress Disorder Therapeutics Market: By Product, 2022-2032, USD (Million)
9.6.1.2.4. Post-Traumatic Stress Disorder Therapeutics Market: By End User, 2022-2032, USD (Million)
9.6.1.3. Rest of North America
9.6.1.3.1. Post-Traumatic Stress Disorder Therapeutics Market: By Stage, 2022-2032, USD (Million)
9.6.1.3.2. Post-Traumatic Stress Disorder Therapeutics Market: By Age Specific, 2022-2032, USD (Million)
9.6.1.3.3. Post-Traumatic Stress Disorder Therapeutics Market: By Product, 2022-2032, USD (Million)
9.6.1.3.4. Post-Traumatic Stress Disorder Therapeutics Market: By End User, 2022-2032, USD (Million)

10. UK and European Union Post-Traumatic Stress Disorder Therapeutics Market, 2022-2032, USD (Million)
10.1. Market Overview
10.2. Post-Traumatic Stress Disorder Therapeutics Market: By Stage, 2022-2032, USD (Million)
10.3. Post-Traumatic Stress Disorder Therapeutics Market: By Age Specific, 2022-2032, USD (Million)
10.4. Post-Traumatic Stress Disorder Therapeutics Market: By Product, 2022-2032, USD (Million)
10.5. Post-Traumatic Stress Disorder Therapeutics Market: By End User, 2022-2032, USD (Million)
10.6.Post-Traumatic Stress Disorder Therapeutics Market: By Region, 2022-2032, USD (Million)
10.6.1.UK and European Union
10.6.1.1. UK
10.6.1.1.1. Post-Traumatic Stress Disorder Therapeutics Market: By Stage, 2022-2032, USD (Million)
10.6.1.1.2. Post-Traumatic Stress Disorder Therapeutics Market: By Age Specific, 2022-2032, USD (Million)
10.6.1.1.3. Post-Traumatic Stress Disorder Therapeutics Market: By Product, 2022-2032, USD (Million)
10.6.1.1.4. Post-Traumatic Stress Disorder Therapeutics Market: By End User, 2022-2032, USD (Million)
10.6.1.2. Germany
10.6.1.2.1. Post-Traumatic Stress Disorder Therapeutics Market: By Stage, 2022-2032, USD (Million)
10.6.1.2.2. Post-Traumatic Stress Disorder Therapeutics Market: By Age Specific, 2022-2032, USD (Million)
10.6.1.2.3. Post-Traumatic Stress Disorder Therapeutics Market: By Product, 2022-2032, USD (Million)
10.6.1.2.4. Post-Traumatic Stress Disorder Therapeutics Market: By End User, 2022-2032, USD (Million)
10.6.1.3. Spain
10.6.1.3.1. Post-Traumatic Stress Disorder Therapeutics Market: By Stage, 2022-2032, USD (Million)
10.6.1.3.2. Post-Traumatic Stress Disorder Therapeutics Market: By Age Specific, 2022-2032, USD (Million)
10.6.1.3.3. Post-Traumatic Stress Disorder Therapeutics Market: By Product, 2022-2032, USD (Million)
10.6.1.3.4. Post-Traumatic Stress Disorder Therapeutics Market: By End User, 2022-2032, USD (Million)
10.6.1.4. Italy
10.6.1.4.1. Post-Traumatic Stress Disorder Therapeutics Market: By Stage, 2022-2032, USD (Million)
10.6.1.4.2. Post-Traumatic Stress Disorder Therapeutics Market: By Age Specific, 2022-2032, USD (Million)
10.6.1.4.3. Post-Traumatic Stress Disorder Therapeutics Market: By Product, 2022-2032, USD (Million)
10.6.1.4.4. Post-Traumatic Stress Disorder Therapeutics Market: By End User, 2022-2032, USD (Million)
10.6.1.5. France
10.6.1.5.1. Post-Traumatic Stress Disorder Therapeutics Market: By Stage, 2022-2032, USD (Million)
10.6.1.5.2. Post-Traumatic Stress Disorder Therapeutics Market: By Age Specific, 2022-2032, USD (Million)
10.6.1.5.3. Post-Traumatic Stress Disorder Therapeutics Market: By Product, 2022-2032, USD (Million)
10.6.1.5.4. Post-Traumatic Stress Disorder Therapeutics Market: By End User, 2022-2032, USD (Million)
10.6.1.6. Rest of Europe
10.6.1.6.1. Post-Traumatic Stress Disorder Therapeutics Market: By Stage, 2022-2032, USD (Million)
10.6.1.6.2. Post-Traumatic Stress Disorder Therapeutics Market: By Age Specific, 2022-2032, USD (Million)
10.6.1.6.3. Post-Traumatic Stress Disorder Therapeutics Market: By Product, 2022-2032, USD (Million)
10.6.1.6.4. Post-Traumatic Stress Disorder Therapeutics Market: By End User, 2022-2032, USD (Million)

11. Asia Pacific Post-Traumatic Stress Disorder Therapeutics Market, 2022-2032, USD (Million)
11.1. Market Overview
11.2. Post-Traumatic Stress Disorder Therapeutics Market: By Stage, 2022-2032, USD (Million)
11.3. Post-Traumatic Stress Disorder Therapeutics Market: By Age Specific, 2022-2032, USD (Million)
11.4. Post-Traumatic Stress Disorder Therapeutics Market: By Product, 2022-2032, USD (Million)
11.5. Post-Traumatic Stress Disorder Therapeutics Market: By End User, 2022-2032, USD (Million)
11.6.Post-Traumatic Stress Disorder Therapeutics Market: By Region, 2022-2032, USD (Million)
11.6.1.Asia Pacific
11.6.1.1. China
11.6.1.1.1. Post-Traumatic Stress Disorder Therapeutics Market: By Stage, 2022-2032, USD (Million)
11.6.1.1.2. Post-Traumatic Stress Disorder Therapeutics Market: By Age Specific, 2022-2032, USD (Million)
11.6.1.1.3. Post-Traumatic Stress Disorder Therapeutics Market: By Product, 2022-2032, USD (Million)
11.6.1.1.4. Post-Traumatic Stress Disorder Therapeutics Market: By End User, 2022-2032, USD (Million)
11.6.1.2. Japan
11.6.1.2.1. Post-Traumatic Stress Disorder Therapeutics Market: By Stage, 2022-2032, USD (Million)
11.6.1.2.2. Post-Traumatic Stress Disorder Therapeutics Market: By Age Specific, 2022-2032, USD (Million)
11.6.1.2.3. Post-Traumatic Stress Disorder Therapeutics Market: By Product, 2022-2032, USD (Million)
11.6.1.2.4. Post-Traumatic Stress Disorder Therapeutics Market: By End User, 2022-2032, USD (Million)
11.6.1.3. India
11.6.1.3.1. Post-Traumatic Stress Disorder Therapeutics Market: By Stage, 2022-2032, USD (Million)
11.6.1.3.2. Post-Traumatic Stress Disorder Therapeutics Market: By Age Specific, 2022-2032, USD (Million)
11.6.1.3.3. Post-Traumatic Stress Disorder Therapeutics Market: By Product, 2022-2032, USD (Million)
11.6.1.3.4. Post-Traumatic Stress Disorder Therapeutics Market: By End User, 2022-2032, USD (Million)
11.6.1.4. Australia
11.6.1.4.1. Post-Traumatic Stress Disorder Therapeutics Market: By Stage, 2022-2032, USD (Million)
11.6.1.4.2. Post-Traumatic Stress Disorder Therapeutics Market: By Age Specific, 2022-2032, USD (Million)
11.6.1.4.3. Post-Traumatic Stress Disorder Therapeutics Market: By Product, 2022-2032, USD (Million)
11.6.1.4.4. Post-Traumatic Stress Disorder Therapeutics Market: By End User, 2022-2032, USD (Million)
11.6.1.5. South Korea
11.6.1.5.1. Post-Traumatic Stress Disorder Therapeutics Market: By Stage, 2022-2032, USD (Million)
11.6.1.5.2. Post-Traumatic Stress Disorder Therapeutics Market: By Age Specific, 2022-2032, USD (Million)
11.6.1.5.3. Post-Traumatic Stress Disorder Therapeutics Market: By Product, 2022-2032, USD (Million)
11.6.1.5.4. Post-Traumatic Stress Disorder Therapeutics Market: By End User, 2022-2032, USD (Million)
11.6.1.6. Rest of Asia Pacific
11.6.1.6.1. Post-Traumatic Stress Disorder Therapeutics Market: By Stage, 2022-2032, USD (Million)
11.6.1.6.2. Post-Traumatic Stress Disorder Therapeutics Market: By Age Specific, 2022-2032, USD (Million)
11.6.1.6.3. Post-Traumatic Stress Disorder Therapeutics Market: By Product, 2022-2032, USD (Million)
11.6.1.6.4. Post-Traumatic Stress Disorder Therapeutics Market: By End User, 2022-2032, USD (Million)

12. Latin America Post-Traumatic Stress Disorder Therapeutics Market, 2022-2032, USD (Million)
12.1. Market Overview
12.2. Post-Traumatic Stress Disorder Therapeutics Market: By Stage, 2022-2032, USD (Million)
12.3. Post-Traumatic Stress Disorder Therapeutics Market: By Age Specific, 2022-2032, USD (Million)
12.4. Post-Traumatic Stress Disorder Therapeutics Market: By Product, 2022-2032, USD (Million)
12.5. Post-Traumatic Stress Disorder Therapeutics Market: By End User, 2022-2032, USD (Million)
12.6.Post-Traumatic Stress Disorder Therapeutics Market: By Region, 2022-2032, USD (Million)
12.6.1.Latin America
12.6.1.1. Brazil
12.6.1.1.1. Post-Traumatic Stress Disorder Therapeutics Market: By Stage, 2022-2032, USD (Million)
12.6.1.1.2. Post-Traumatic Stress Disorder Therapeutics Market: By Age Specific, 2022-2032, USD (Million)
12.6.1.1.3. Post-Traumatic Stress Disorder Therapeutics Market: By Product, 2022-2032, USD (Million)
12.6.1.1.4. Post-Traumatic Stress Disorder Therapeutics Market: By End User, 2022-2032, USD (Million)
12.6.1.2. Mexico
12.6.1.2.1. Post-Traumatic Stress Disorder Therapeutics Market: By Stage, 2022-2032, USD (Million)
12.6.1.2.2. Post-Traumatic Stress Disorder Therapeutics Market: By Age Specific, 2022-2032, USD (Million)
12.6.1.2.3. Post-Traumatic Stress Disorder Therapeutics Market: By Product, 2022-2032, USD (Million)
12.6.1.2.4. Post-Traumatic Stress Disorder Therapeutics Market: By End User, 2022-2032, USD (Million)
12.6.1.3. Rest of Latin America
12.6.1.3.1. Post-Traumatic Stress Disorder Therapeutics Market: By Stage, 2022-2032, USD (Million)
12.6.1.3.2. Post-Traumatic Stress Disorder Therapeutics Market: By Age Specific, 2022-2032, USD (Million)
12.6.1.3.3. Post-Traumatic Stress Disorder Therapeutics Market: By Product, 2022-2032, USD (Million)
12.6.1.3.4. Post-Traumatic Stress Disorder Therapeutics Market: By End User, 2022-2032, USD (Million)

13. Middle East and Africa Post-Traumatic Stress Disorder Therapeutics Market, 2022-2032, USD (Million)
13.1. Market Overview
13.2. Post-Traumatic Stress Disorder Therapeutics Market: By Stage, 2022-2032, USD (Million)
13.3. Post-Traumatic Stress Disorder Therapeutics Market: By Age Specific, 2022-2032, USD (Million)
13.4. Post-Traumatic Stress Disorder Therapeutics Market: By Product, 2022-2032, USD (Million)
13.5. Post-Traumatic Stress Disorder Therapeutics Market: By End User, 2022-2032, USD (Million)
13.6.Post-Traumatic Stress Disorder Therapeutics Market: By Region, 2022-2032, USD (Million)
13.6.1.Middle East and Africa
13.6.1.1. GCC
13.6.1.1.1. Post-Traumatic Stress Disorder Therapeutics Market: By Stage, 2022-2032, USD (Million)
13.6.1.1.2. Post-Traumatic Stress Disorder Therapeutics Market: By Age Specific, 2022-2032, USD (Million)
13.6.1.1.3. Post-Traumatic Stress Disorder Therapeutics Market: By Product, 2022-2032, USD (Million)
13.6.1.1.4. Post-Traumatic Stress Disorder Therapeutics Market: By End User, 2022-2032, USD (Million)
13.6.1.2. Africa
13.6.1.2.1. Post-Traumatic Stress Disorder Therapeutics Market: By Stage, 2022-2032, USD (Million)
13.6.1.2.2. Post-Traumatic Stress Disorder Therapeutics Market: By Age Specific, 2022-2032, USD (Million)
13.6.1.2.3. Post-Traumatic Stress Disorder Therapeutics Market: By Product, 2022-2032, USD (Million)
13.6.1.2.4. Post-Traumatic Stress Disorder Therapeutics Market: By End User, 2022-2032, USD (Million)
13.6.1.3. Rest of Middle East and Africa
13.6.1.3.1. Post-Traumatic Stress Disorder Therapeutics Market: By Stage, 2022-2032, USD (Million)
13.6.1.3.2. Post-Traumatic Stress Disorder Therapeutics Market: By Age Specific, 2022-2032, USD (Million)
13.6.1.3.3. Post-Traumatic Stress Disorder Therapeutics Market: By Product, 2022-2032, USD (Million)
13.6.1.3.4. Post-Traumatic Stress Disorder Therapeutics Market: By End User, 2022-2032, USD (Million)

14. Company Profile
14.1. Pfizer
14.1.1. Company Overview
14.1.2. Financial Performance
14.1.3. Product Portfolio
14.1.4. Strategic Initiatives
14.2. Novartis AG
14.2.1. Company Overview
14.2.2. Financial Performance
14.2.3. Product Portfolio
14.2.4. Strategic Initiatives
14.3. GlaxoSmithKline plc
14.3.1. Company Overview
14.3.2. Financial Performance
14.3.3. Product Portfolio
14.3.4. Strategic Initiatives
14.4. Bionomics Ltd.
14.4.1. Company Overview
14.4.2. Financial Performance
14.4.3. Product Portfolio
14.4.4. Strategic Initiatives
14.5. Otsuka Pharmaceutical Co. Ltd
14.5.1. Company Overview
14.5.2. Financial Performance
14.5.3. Product Portfolio
14.5.4. Strategic Initiatives
14.6. Biosciences Inc.
14.6.1. Company Overview
14.6.2. Financial Performance
14.6.3. Product Portfolio
14.6.4. Strategic Initiatives
14.7. Azevan Pharmaceuticals Inc.
14.7.1. Company Overview
14.7.2. Financial Performance
14.7.3. Product Portfolio
14.7.4. Strategic Initiatives
14.8. AstraZeneca Plc
14.8.1. Company Overview
14.8.2. Financial Performance
14.8.3. Product Portfolio
14.8.4. Strategic Initiatives
14.9. Tonix Pharmaceuticals Holding Corp.
14.9.1. Company Overview
14.9.2. Financial Performance
14.9.3. Product Portfolio
14.9.4. Strategic Initiatives
14.10. Apotex Inc.
14.10.1. Company Overview
14.10.2. Financial Performance
14.10.3. Product Portfolio
14.10.4. Strategic Initiatives